Psychiatrists are increasingly called upon to evaluate somatic and psychiatric symptoms and differentiate them from possible iatrogenic effects of psychotropic medications. The growing use of multidrug regimens for major psychiatric disorders makes such distinctions all the more challenging. Teasing apart side effects from primary illness symptoms is often complex and requires a facile working knowledge of diverse end-organ drug effects and pharmacokinetic interactions, recognition of subpopulations at increased risk for adverse effects, and awareness of plausible versus unlikely pharmacodynamics effects. This presentation focuses on reviewing systematic approaches for assessing and managing suspected adverse effects from psychotropic drugs, by focusing on methods for anticipating and recognizing possible adverse drug effects, managing the interplay between perceived adverse effects and medication adherence, distinguishing medically serious from non-serious adverse effects, and detecting clinical and pharmacogenetic risk factors that increase propensity for specific adverse effects.
**This content was captured at the 2017 APA Annual Meeting and may reference information from various sources and terminology from previous editions of the DSM.
FREE - $0
Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. (Effective January 1, 2019)
- Recognize clinical predictors of adverse drug effects and methods to assess and minimize their impact on treatment outcomes
- Identify pharmacogenetic predictors of adverse effects from psychotropic medications
- Describe strategies for managing and counteracting adverse metabolic, neurological and genitourinary adverse psychotropic drug effects
Estimated Time to Complete
Estimated Duration: 30 minutes
Begin Date: June 1, 2018
End Date: December 31, 2020
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 100% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
Continuing Education Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The APA designates this enduring CME activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
- Joseph F. Goldberg, M.D., Icahn School of Medicine. Disclosures: (Consultant/Advisory Board) MedScape, Sunovion Pharmaceuticals Inc., Supernus, WebMD; (Speakers Bureau/Speaker Honoraria) Merck & Co., Sunovion, Pharmaceuticals Inc., Takeda Pharmaceuticals, Vanda Pharmaceuticals.
- Tristan Gorrindo, M.D., Director of Education, American Psychiatric Association. Reports no financial relationships with commercial interests.
- Ricardo A. Juarez, M.S., Director, District Branch and International Relations, American Psychiatric Association. Reports no financial relationships with commercial interests.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
Need Assistance? contact email@example.com for questions about this course | contact firstname.lastname@example.org for technical assistance
All materials copyright American Psychiatric Association ©2018.